Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Kencor Health›
Analysis
AddedFeb 16, 2024
UpdatedJun 25, 2026
Kencor Health

Kencor Health

Kencor Health offers an AI-powered remote care platform combining RPM, CCM, and RTM to support patients and providers.

HQ
Sunnyvale, CA, US
Founded
2015
Loading
Overview
Analysis
Compare
Fundraising
Employees
News
Website

Contents

  1. 01Executive Summary
  2. 02Products & Services
  3. 03Competitive Strengths
  1. 01Executive Summary
  2. 02Products & Services
  3. 03Competitive Strengths

Memo

Kencor Health serves physician practices, health systems, and payers with an AI-informed remote care platform. The company’s focus in 2026 is on scaling value-based programs—RPM, CCM, and RTM—while navigating payer reimbursement changes and expanding partnerships such as its Venture Dock presence.

Key priorities include clinical governance under the new Chief Medical Officer, measurable reductions in readmissions and ED visits, and seamless EHR integrations that keep provider workflows lightweight.

Product Overview

Kencor Health’s SAMi platform is an AI-powered virtual care companion that supports Remote Patient Monitoring (RPM), Chronic Care Management (CCM), and Remote Therapeutic Monitoring (RTM). It combines connected devices, a patient app, real-time alerts, EHR integration, and care-team oversight.

The platform helps practices manage chronic conditions between visits, improve adherence, reduce hospitalizations, and capture recurring reimbursement through a human-plus-AI monitoring model.

Competitive Advantages

Kencor Health differentiates itself through a human-plus-AI hybrid monitoring model, end-to-end RPM/CCM/RTM operations, seamless bi-directional EHR integration, multilingual care coordination, and device-agnostic connectivity.

The platform emphasizes early detection, audit-ready documentation, and measurable outcomes such as reduced readmissions and improved blood-pressure and glucose control.